A team of leading clinical research scientists from the Departments of Psychiatry and Dermatology at the Icahn School of ...

FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and drug label updates.

In the future, psychedelics may be used to treat addictions because they can shake up the brain. Along with therapy, ...

Psychedelics are psychoactive substances that trigger unusual mental states, also referred to as "trips," altering the ...

Could a smart watch act as an early‑warning system for depression relapse? New research from McMaster University suggests ...

A new UT Austin clinical trial is testing a fast‑acting treatment for postpartum depression that doesn’t require drugs, ...

Could a smart watch act as an early-warning system for depression relapse? New research from McMaster University suggests that disruptions in a person's sleep and daily activity routine, as detected ...

News and commentary from the psychiatry world ...

As of Wednesday, February 11, Neuronetics, Inc.’s STIM share price has surged by 21.58%, which has investors questioning if this is right time to sell.

Neurocrine Biosciences, Inc. ( NBIX) Q4 2025 Earnings Call February 11, 2026 4:30 PM EST ...

For the full year 2025, Neurocrine reported total net product sales of $2.83 billion, a 22% increase from the previous year. INGREZZA sales grew 9% to $2.51 billion, while CRENESSITY, which was ...

Confusion about the safety of taking the drugs during pregnancy has led to mental health emergencies for some expectant ...